Cover Image

Grover disease associated with docetaxel chemotherapy

Saved in:

Bibliographic Details
Main Authors:	Shawn Afvari, BS (Author), Melvin W. Chiu, MD, MPH (Author)
Format:	Book
Published:	Elsevier, 2022-11-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Grover's disease
by: Olivia Jakubowicz-Zalewska, et al.
Published: (2020)

Successful treatment of resistant Grover's disease with dupilumab
by: Jessica Forbes Kaprive, DO, et al.
Published: (2024)

Case for diagnosis. Atypical Grover's disease,
by: Pablo Vargas-Mora, et al.
Published: (2021)

Novel use of acitretin for posttransplant Grover's disease and cutaneous graft versus host disease
by: Neha Gupta, MPH, et al.
Published: (2023)

Association of bullous pemphigoid and Grover disease induced by immune checkpoint therapy
by: Elena Lucía Pinto-Pulido, et al.
Published: (2024)

Neutrophil-rich Variant of Persistent Bullous Grover's Disease
by: Sayaka Togo, et al.
Published: (2019)

Grover's disease: dermoscopy, reflectance confocal microscopy, and histopathological correlation
by: Francesco Lacarrubba, et al.
Published: (2017)

Periungual lesions secondary to chemotherapy with docetaxel
by: Dawid Sigorski, et al.
Published: (2020)

Grover's disease with acrosyringeal acantholysis: A rare histological presentation of an uncommon disease
by: Rajiv Joshi, et al.
Published: (2014)

Bullous Grover’s Disease in a Chinese Tibetan Adolescent: A Case Report
by: Wang Q, et al.
Published: (2022)

Trastuzumab-Docetaxel combination chemotherapy induced severe onychopathy
by: Sidharth Sonthalia, et al.
Published: (2017)

Gemcitabine and docetaxel combination chemotherapy induced dermatomyositis associated with hand-foot syndrome
by: Mayuko Kawada, et al.
Published: (2021)

Clostridium difficile Colitis and Neutropenic Fever Associated with Docetaxel Chemotherapy in a Patient with Advanced Extramammary Paget's Disease
by: Yumi Nonomura, et al.
Published: (2012)

Type I hypersensitivity in photoallergic contact dermatitis
by: Shawn Afvari, BS, et al.
Published: (2024)

A Case of Extensive Grover's Disease in a Patient with a History of Multiple Non-Melanoma Skin Cancers
by: Mareike Kotzerke, et al.
Published: (2021)

A Compilation of the Messages and Papers of the Presidents. Volume 8, part 2: Grover Cleveland
by: Cleveland, Grover, 1837-1908; Richardson, James D. (James Daniel), 1843-1914 [Editor]

Co-encapsulation of docetaxel and cyclosporin A into SNEDDS to promote oral cancer chemotherapy
by: Weiping Cui, et al.
Published: (2019)

Results of combination treatment using docetaxel in an adjuvant chemotherapy regimen for resectable breast cancer
by: L. V. Bolotina, et al.
Published: (2014)

Histopathological Efficacy of Docetaxel Versus Paclitaxel As First Line Chemotherapy for Epithelial Ovarian Carcinoma
by: Tayyup Şimşek, et al.
Published: (2008)

Relapse or recall? Docetaxel-associated re-emergence of paraneoplastic dermatomyositis
by: Drew Kuraitis, MD, PhD, et al.
Published: (2024)

Multiple metastasized extramammary Paget's disease cured with bisphosphonate risedronate sodium after CyberKnife radiosurgery and docetaxel chemotherapy
by: Taku Fujimura, et al.
Published: (2016)

A Compilation of the Messages and Papers of the Presidents. Volume 8, part 3: Grover Cleveland, First Term
by: Cleveland, Grover, 1837-1908; Richardson, James D. (James Daniel), 1843-1914 [Editor]

mPEG-PDLLA Micelles Potentiate Docetaxel for Intraperitoneal Chemotherapy in Ovarian Cancer Peritoneal Metastasis
by: Yumei Zhang, et al.
Published: (2022)

Docetaxel prodrug and hematoporphyrin co-assembled nanoparticles for anti-tumor combination of chemotherapy and photodynamic therapy
by: Guolian Ren, et al.
Published: (2022)

Co-delivery of docetaxel and bortezomib based on a targeting nanoplatform for enhancing cancer chemotherapy effects
by: Junpeng Nie, et al.
Published: (2017)

A Rare Case of Transient Acantholytic Dermatosis (AKA. Grover's Disease) with Concomitant Pediculosis Pubis: An Atypical Presentation and First Documented Case Report
by: Gehan A. Pendlebury, et al.
Published: (2021)

Docetaxel extravasation: Pathologic correlation and treatment with intralesional steroids
by: John W. Roman, MD, et al.
Published: (2017)

SINGLE AGENT DOCETAXEL AS SECOND- LINE CHEMOTHERAPY FOR PRETREATED PATIENTS WITH RECURRENT NON- SMALL CELL LUNG CANCER
by: Deyan N. Davidov
Published: (2013)

Intensified dose-dense neoadjuvant chemotherapy using paclitaxel-gemcitabine and docetaxel-doxorubicin combinations for locally advanced breast cancer
by: I. V. Frai, et al.
Published: (2014)

Changes in biological markers, particularly hormone receptors, due to pre-operative chemotherapy (epirubicin/docetaxel) in operable breast cancer
by: Rumiko Tashima, et al.
Published: (2011)

Chemotherapy-Induced Peripheral Neurotoxicity as A Risk Factor for Poor Sleep Quality in Breast Cancer Survivors Treated with Docetaxel
by: Ya-Ning Chan, et al.
Published: (2021)

Anetoderma may be a warning sign of autoimmunity: A cohort study
by: Shawn Afvari, BS, et al.
Published: (2024)

A Letter to Grover Cleveland On His False Inaugural Address, The Usurpations and Crimes of Lawmakers and Judges, and the Consequent Poverty, Ignorance, and Servitude Of The People
by: Spooner, Lysander, 1808-1887

Severe acral erythrodysesthesia and docetaxel
by: Justin Bagorane, et al.
Published: (2021)

Docetaxel-related interstitial pneumonitis
by: Wang CJ, et al.
Published: (2015)

Factors Associated with Absolute Neutrophil Count Dynamics and Docetaxel-Adryamicin-Cyclophosphamide (TAC) Chemotherapy Induced Neutropenia During Extended Filgrastim Administration in Breast Cancer Patients
by: Ami Ashariati, et al.
Published: (2022)

Complete remission in very advanced oral cancer by docetaxel, cisplatin, 5-fluorouracil based induction chemotherapy followed by concurrent chemoradiation
by: Tien-En Chiang, et al.
Published: (2018)

Efficacy of docetaxel, cisplatin, and 5-fluorouracil as an induction chemotherapy in oral squamous cell carcinoma in a tertiary hospital in Saudi Arabia
by: Mohammad Alessa, et al.
Published: (2024)

Cost-Effectiveness of Nivolumab Immunotherapy vs. Paclitaxel or Docetaxel Chemotherapy as Second-Line Therapy in Advanced Esophageal Squamous Cell Carcinoma in China
by: Ying-tao Lin, et al.
Published: (2022)

Maintenance therapy with oral etoposide following first-line docetaxel-cisplatin chemotherapy in metastatic non-small cell lung cancer patients
by: Meiyu Fang, et al.
Published: (2012)